|
|
|
Insider
Information: |
Hale David F |
Relationship: |
|
City: |
Carlsbad |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
101,472 |
|
Indirect Shares
|
755,264 |
|
|
Direct
Value |
$5,685 |
|
|
Indirect Value
|
$41,765 |
|
|
Total
Shares |
856,736 |
|
|
Total
Value |
$47,449 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Santarus Inc |
SNTS |
Director |
2014-01-02 |
0 |
2014-01-02 |
0 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2013-03-06 |
0 |
2013-03-06 |
0 |
Premium* |
|
Histogen Inc |
HSTO |
Director |
2014-01-08 |
24,242 |
2014-01-08 |
143,739 |
Premium* |
|
Biocept Inc |
BIOC |
Director |
2021-12-09 |
796 |
2021-12-09 |
101 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
Director |
2024-02-23 |
714 |
2024-02-23 |
30,590 |
Premium* |
|
Dermata Therapeutics, Inc. |
DRMA |
|
2022-10-06 |
75,720 |
2022-10-06 |
580,834 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-03-22 |
5 |
GD |
$0.00 |
$0 |
I/I |
9,000 |
351,187 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-03-25 |
5 |
GD |
$0.00 |
$0 |
I/I |
600 |
350,587 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-03-29 |
5 |
GD |
$0.00 |
$0 |
I/I |
3,000 |
347,587 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,291 |
40,666 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-06-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,600 |
345,987 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-11-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,050 |
468,630 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
550 |
468,080 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-12-01 |
4 |
AS |
$2.68 |
$289,585 |
I/I |
(107,893) |
360,187 |
0 |
- |
|
SNTS |
Santarus Inc |
Director |
|
2010-12-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
130,739 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-12-22 |
5 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
343,987 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-12-23 |
5 |
GD |
$0.00 |
$0 |
I/I |
6,000 |
337,987 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2011-05-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,000 |
322,987 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2011-08-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,200 |
320,787 |
0 |
- |
|
SNTS |
Santarus Inc |
Director |
|
2012-03-21 |
4 |
OE |
$0.88 |
$152,969 |
I/I |
89,713 |
220,452 |
0 |
- |
|
SNTS |
Santarus Inc |
Director |
|
2012-03-21 |
4 |
B |
$5.34 |
$96,173 |
D/D |
18,000 |
18,000 |
2.39 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
152,308 |
152,308 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
144,951 |
297,259 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
137,586 |
434,845 |
0 |
- |
|
SNTS |
Santarus Inc |
Director |
|
2012-12-12 |
4 |
OE |
$2.02 |
$188,580 |
I/I |
84,000 |
304,452 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
16,033 |
70,388 |
0 |
- |
|
SNTS |
Santarus Inc |
Director |
|
2012-12-31 |
5 |
GD |
$0.00 |
$0 |
I/I |
4,000 |
300,452 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2013-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(70,388) |
0 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2013-03-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(40,098) |
0 |
0 |
- |
|
HSTO |
Histogen Inc |
Director |
|
2013-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
121,211 |
|
- |
|
HSTO |
Histogen Inc |
Director |
|
2013-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
19,679 |
140,890 |
0 |
- |
|
86 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|